SC 13G Filing

Company

Day One Biopharmaceuticals, Inc.

Filed

November 7, 2024

Accession Number

0000315066-24-002574

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →